Karl E Minges1, Paul Zimmet2, Dianna J Magliano2, David W Dunstan3, Alex Brown4, Jonathan E Shaw2. 1. Baker IDI Heart and Diabetes Institute, Melbourne, Australia. Electronic address: kem2147@columbia.edu. 2. Baker IDI Heart and Diabetes Institute, Melbourne, Australia; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia. 3. Baker IDI Heart and Diabetes Institute, Melbourne, Australia; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia; The University of Queensland, School of Population Health, Cancer Prevention Research Centre, Brisbane, Australia; School of Exercise and Nutrition Sciences, Deakin University, Melbourne, Australia; ECU Health and Wellness Institute, Edith Cowan University, Perth, Australia. 4. Baker IDI Heart and Diabetes Institute, Melbourne, Australia; Baker IDI Heart and Diabetes Institute, Centre for Indigenous Vascular and Diabetes Research, Alice Springs, NT, Australia.
Abstract
AIMS: To perform a systematic review of the prevalence of diabetes and impaired glucose tolerance (IGT) in Indigenous Australians in order to clarify overall patterns, by determinants such as age, gender, region, ethnicity and remoteness. METHODS: The OVID interface to Medline and the Australian Indigenous HealthInfoNet databases were systematically searched from years 1997 to 2010. Studies reporting diabetes prevalence were included if they used population-based samples of Indigenous Australians. Diagnosis of diabetes was based on self-report or standard diagnostic criteria. RESULTS: Twenty-four studies were included. The diabetes prevalence ranged from 3.5 to 33.1%; IGT estimates ranged from 4.7 to 21.1%. Prevalence was greater among Indigenous Australian women compared to men, the Northern Territory's Top End compared to Central Australia, Torres Strait Islanders compared to Aboriginals, older (≥35 years) compared to younger (<35 years) age groups, and remote compared to urban settings. Patterns of IGT prevalence were similar to those observed for diabetes. CONCLUSIONS: Although the prevalence of diabetes and IGT is high, there appears to be considerable variation in prevalence between different segments of the Australian Indigenous population. Data on diabetes prevalence in the urban Australian Indigenous population is lacking, despite accounting for almost three quarters of the total population.
AIMS: To perform a systematic review of the prevalence of diabetes and impaired glucose tolerance (IGT) in Indigenous Australians in order to clarify overall patterns, by determinants such as age, gender, region, ethnicity and remoteness. METHODS: The OVID interface to Medline and the Australian Indigenous HealthInfoNet databases were systematically searched from years 1997 to 2010. Studies reporting diabetes prevalence were included if they used population-based samples of Indigenous Australians. Diagnosis of diabetes was based on self-report or standard diagnostic criteria. RESULTS: Twenty-four studies were included. The diabetes prevalence ranged from 3.5 to 33.1%; IGT estimates ranged from 4.7 to 21.1%. Prevalence was greater among Indigenous Australian women compared to men, the Northern Territory's Top End compared to Central Australia, Torres Strait Islanders compared to Aboriginals, older (≥35 years) compared to younger (<35 years) age groups, and remote compared to urban settings. Patterns of IGT prevalence were similar to those observed for diabetes. CONCLUSIONS: Although the prevalence of diabetes and IGT is high, there appears to be considerable variation in prevalence between different segments of the Australian Indigenous population. Data on diabetes prevalence in the urban Australian Indigenous population is lacking, despite accounting for almost three quarters of the total population.
Authors: Matthew J L Hare; Yuejen Zhao; Steven Guthridge; Paul Burgess; Elizabeth L M Barr; Elna Ellis; Deborah Butler; Amy Rosser; Henrik Falhammar; Louise J Maple-Brown Journal: BMJ Open Date: 2022-05-15 Impact factor: 3.006
Authors: Robert J Commons; Claire H Robinson; David Gawler; Joshua S Davis; Ric N Price Journal: Diabetes Res Clin Pract Date: 2015-09-21 Impact factor: 5.602
Authors: Alanna Sorenson; Leigh Owens; Marie Caltabiano; Yvonne Cadet-James; Roy Hall; Brenda Govan; Paula Clancy Journal: Am J Trop Med Hyg Date: 2016-03-21 Impact factor: 2.345
Authors: Timothy M E Davis; Kerry Hunt; Daniel McAullay; Stephen A P Chubb; Brett A Sillars; David G Bruce; Wendy A Davis Journal: Diabetes Care Date: 2012-07-18 Impact factor: 19.112
Authors: David Ross Johnson; Robyn Anne McDermott; Peter Marshall Clifton; Katina D'Onise; Sean Matthew Taylor; Cilla Louise Preece; Barbara Anne Schmidt Journal: BMC Public Health Date: 2015-04-03 Impact factor: 3.295
Authors: Laima Brazionis; Anthony Keech; Christopher Ryan; Alex Brown; David O'Neal; John Boffa; Sven-Erik Bursell; Alicia Jenkins Journal: BMJ Open Ophthalmol Date: 2021-07-01